Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer

Author:

Ladd Mary Kathleen12ORCID,Peshkin Beth N12,Senter Leigha3,Baldinger Shari4,Isaacs Claudine12ORCID,Segal Hannah12,Philip Samantha12,Phillips Chloe12,Shane Kate3,Martin Aimee12,Weinstein Veronique12,Pilarski Robert3,Jeter Joanne3,Sweet Kevin3,Hatten Bonnie4,Wurtmann Elisabeth J4,Phippen Shanda4,Bro Della4,Schwartz Marc D12

Affiliation:

1. Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

2. Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, DC

3. Division of Human Genetics, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH

4. Virgina Piper Cancer Institute, Allina Health, Minneapolis, MN

Abstract

Abstract Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are increasingly used to reduce breast and ovarian cancer risk following BRCA1/BRCA2 testing. However, little is known about how genetic counseling influences decisions about these surgeries. Although previous studies have examined intentions prior to counseling, few have examined RRM and RRSO intentions in the critical window between genetic counseling and test result disclosure. Previous research has indicated that intentions at this time point predict subsequent uptake of surgery, suggesting that much decision-making has taken place prior to result disclosure. This period may be a critical time to better understand the drivers of prophylactic surgery intentions. The aim of this study was to examine predictors of RRM and RRSO intentions. We hypothesized that variables from the Health Belief Model would predict intentions, and we also examined the role of affective factors. Participants were 187 women, age 21–75, who received genetic counseling for hereditary breast and ovarian cancer. We utilized multiple logistic regression to identify independent predictors of intentions. 49.2% and 61.3% of participants reported intentions for RRM and RRSO, respectively. Variables associated with RRM intentions include: newly diagnosed with breast cancer (OR = 3.63, 95% CI = 1.20–11.04), perceived breast cancer risk (OR = 1.46, 95% CI = 1.17–1.81), perceived pros (OR = 1.79, 95% CI = 1.38–2.32) and cons of RRM (OR = 0.81, 95% CI = 0.65–0.996), and decision conflict (OR = 0.80, 95% CI = 0.66–0.98). Variables associated with RRSO intentions include: proband status (OR = 0.28, 95% CI = 0.09–0.89), perceived pros (OR = 1.35, 95% CI = 1.11–1.63) and cons of RRSO (OR = 0.72, 95% CI = 0.59–0.89), and ambiguity aversion (OR = 0.79, 95% CI = 0.65–0.95). These data provide support for the role of genetic counseling in fostering informed decisions about risk management, and suggest that the role of uncertainty should be explored further.

Funder

Survey, Recruitment and Biospecimen Collection Shared Resource of the Lombardi Comprehensive Cancer Center

Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research

National Institutes of Health

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Behavioral Neuroscience,Applied Psychology

Reference47 articles.

1. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

2. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers;Rebbeck;J Natl Cancer Inst,2009

3. Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers;Kotsopoulos;J Natl Cancer Inst,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3